Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
bnt162b2 (Comirnaty) (1 trial)
chulacov19 mrna vaccine (1 trial)
gnbac1 (1 trial)
artemether (1 trial)
bsi-045b (1 trial)
doco-pro-rbd-1 (1 trial)
lactobacillus plantarum (1 trial)
lat8881 (1 trial)
lumefantrine (Coartem) (1 trial)
mf59 (1 trial)
mmv367 (1 trial)
mmv 533 (1 trial)
mmv688533 (1 trial)
pyronaridine (1 trial)
ruxolitinib (jakafi) (1 trial)
sars-cov-2 mrna vaccine (1 trial)
Diabetes Mellitus (Phase 2)
Diabetes Mellitus, Type 1 (Phase 2)
Malaria (Phase 1)
Trials (11 total)
Trial APIs (16 total)